Dr. Tushar N. Mehta
Advertisement
Articles by Dr. Tushar N. Mehta
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
China Grants Ivonescimab Priority Review in Biliary Tract Cancer
2
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
3
Caldera’s IL-23p19×TL1A Bispecific CLD-423 Shows 40-Day Half-Life in Phase 1a, Supporting Dosing Every 8 to 12 Weeks
4
Boehringer Ingelheim Licenses Six Preclinical ADC and T-Cell Engager Programs From SBP Group in Deal Worth Up to $7 Billion
5